메뉴 건너뛰기




Volumn 1, Issue 6, 2002, Pages 403-408

Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPYLTHIO]PHENYL] 4 HYDROXY 3 METHYLBUTYRIC ACID; ACETYLSALICYLIC ACID; ARACHIDONATE 5 LIPOXYGENASE; CORTICOSTEROID DERIVATIVE; LEUKOTRIENE A4; LEUKOTRIENE B4; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MONTELUKAST; PEPTIDOLEUKOTRIENE; PLACEBO; PRANLUKAST; ZAFIRLUKAST; ZILEUTON;

EID: 0042858109     PISSN: 11756365     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03257167     Document Type: Article
Times cited : (16)

References (29)
  • 1
    • 0033590513 scopus 로고    scopus 로고
    • Treatment of asthma with drugs modifying the leukotriene pathway
    • Drazen JM, Israel E, O'Byrne P. Treatment of asthma with drugs modifying the leukotriene pathway. N Engl J Med 1999; 340: 197-206
    • (1999) N. Engl. J. Med. , vol.340 , pp. 197-206
    • Drazen, J.M.1    Israel, E.2    O'Byrne, P.3
  • 2
    • 0033011604 scopus 로고    scopus 로고
    • Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease
    • Busse WW, McGill KA, Horwitz RJ. Leukotriene pathway inhibitors in asthma and chronic obstructive pulmonary disease. Clin Exp Allergy 1999; 29 (S2): S110-5
    • (1999) Clin. Exp. Allergy , vol.29 , Issue.S2
    • Busse, W.W.1    McGill, K.A.2    Horwitz, R.J.3
  • 3
    • 0031047375 scopus 로고    scopus 로고
    • Leukotrienes in the pathogenesis of asthma
    • O'Byrne PM. Leukotrienes in the pathogenesis of asthma. Chest 1997; 111 (S2): S27-34
    • (1997) Chest , vol.111 , Issue.S2
    • O'Byrne, P.M.1
  • 4
    • 0023942170 scopus 로고
    • Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin
    • Ferreri N, Howland WC, Stevenson DD, et al. Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin. Am Rev Respir Dis 1988; 137: 847-54
    • (1988) Am. Rev. Respir. Dis. , vol.137 , pp. 847-854
    • Ferreri, N.1    Howland, W.C.2    Stevenson, D.D.3
  • 5
    • 0030761053 scopus 로고    scopus 로고
    • Antileukotrienes in the treatment of asthma
    • O'Byrne PM, Israel E, Drazen JM. Antileukotrienes in the treatment of asthma. Ann Intern Med 1997; 127 (6): 472-80
    • (1997) Ann. Intern. Med. , vol.127 , Issue.6 , pp. 472-480
    • O'Byrne, P.M.1    Israel, E.2    Drazen, J.M.3
  • 6
    • 0031607546 scopus 로고    scopus 로고
    • The role of antileukotrienes in asthma management
    • Tan RA. The role of antileukotrienes in asthma management. Curr Opin Pulm Med 1998; 4 (1): 25-30
    • (1998) Curr. Opin. Pulm. Med. , vol.4 , Issue.1 , pp. 25-30
    • Tan, R.A.1
  • 7
    • 0031798623 scopus 로고    scopus 로고
    • Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors
    • Drazen J. Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors. Am J Respir Crit Care Med 1998; 157: S233-7
    • (1998) Am. J. Respir. Crit. Care Med. , vol.157
    • Drazen, J.1
  • 8
    • 0031039964 scopus 로고    scopus 로고
    • Worldwide clinical experience with the first marketed leukotriene receptor antagonist
    • Barnes NC, Dejong B, Miyamoto T. Worldwide clinical experience with the first marketed leukotriene receptor antagonist. Chest 1997; 111 (S2): S52-60
    • (1997) Chest , vol.111 , Issue.S2
    • Barnes, N.C.1    Dejong, B.2    Miyamoto, T.3
  • 9
    • 0033574195 scopus 로고    scopus 로고
    • Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma
    • Malmstrom K, Rodriguez-Gomez G, Guerra J, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. Ann Intern Med 1999; 130 (6): 487-95
    • (1999) Ann. Intern. Med. , vol.130 , Issue.6 , pp. 487-495
    • Malmstrom, K.1    Rodriguez-Gomez, G.2    Guerra, J.3
  • 10
    • 0030445953 scopus 로고    scopus 로고
    • Anti-leukotriene agents: A new direction in asthma therapy
    • Nathan RA. Anti-leukotriene agents: a new direction in asthma therapy. J Asthma 1996; 33 (6): 353-66
    • (1996) J. Asthma. , vol.33 , Issue.6 , pp. 353-366
    • Nathan, R.A.1
  • 12
    • 0032929887 scopus 로고    scopus 로고
    • Therapeutic advances: Leukotriene antagonists for the treatment of asthma
    • Misson J, Clark W, Kendall MJ. Therapeutic advances: leukotriene antagonists for the treatment of asthma. J Clin Pharm 1999; 24 (1): 17-22
    • (1999) J. Clin. Pharm. , vol.24 , Issue.1 , pp. 17-22
    • Misson, J.1    Clark, W.2    Kendall, M.J.3
  • 13
    • 0032522735 scopus 로고    scopus 로고
    • Montelukast for chronic asthma in 6- and 14-year old children: A randomized, double-blind trial
    • Knorr B, Matz J, Bernstein JA, et al. Montelukast for chronic asthma in 6- and 14-year old children: a randomized, double-blind trial. JAMA 1998; 279 (15): 1181-6
    • (1998) JAMA , vol.279 , Issue.15 , pp. 1181-1186
    • Knorr, B.1    Matz, J.2    Bernstein, J.A.3
  • 15
    • 0025341987 scopus 로고
    • The effect of a leukotriene antagonist on the early response to antigen
    • Flowers BK, Proud D, Kagey-Sobotka A, et al. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg 1990; 102: 219-24
    • (1990) Otolaryngol. Head Neck Surg. , vol.102 , pp. 219-224
    • Flowers, B.K.1    Proud, D.2    Kagey-Sobotka, A.3
  • 16
    • 0025685169 scopus 로고
    • Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor
    • Knapp HR. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med 1990; 323 (25): 1745-8
    • (1990) N. Engl. J. Med. , vol.323 , Issue.25 , pp. 1745-1748
    • Knapp, H.R.1
  • 17
    • 0028990176 scopus 로고
    • The leukotriene d4-receptor antagonist, ici 204,219, relieves symptoms of acute seasonal allergic rhinitis
    • Donnelly AL, Glass M, Minkwitz MC, et al. The leukotriene d4-receptor antagonist, ici 204,219, relieves symptoms of acute seasonal allergic rhinitis. Am J Respir Crit Care Med 1995; 151: 1734-9
    • (1995) Am. J. Respir. Crit. Care Med. , vol.151 , pp. 1734-1739
    • Donnelly, A.L.1    Glass, M.2    Minkwitz, M.C.3
  • 18
    • 19244370387 scopus 로고    scopus 로고
    • Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics
    • Dahlen B. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Care Med 1998; 157: 1187-94
    • (1998) Am. J. Respir. Care Med. , vol.157 , pp. 1187-1194
    • Dahlen, B.1
  • 19
    • 0024849260 scopus 로고
    • Immunopathology of nasal polyps: An immunohistochemical approach
    • Larocca LM, Maggiano N, Capeli A, et al. Immunopathology of nasal polyps: an immunohistochemical approach. Ann Allergy 1989; 63: 508-51
    • (1989) Ann. Allergy , vol.63 , pp. 508-551
    • Larocca, L.M.1    Maggiano, N.2    Capeli, A.3
  • 20
    • 0023149914 scopus 로고
    • Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa
    • Jung TTK, Juhn SK, Hwang D, et al. Prostaglandins, leukotrienes, and other arachidonic acid metabolites in nasal polyps and nasal mucosa. Laryngoscope 1987; 97: 184-8
    • (1987) Laryngoscope , vol.97 , pp. 184-188
    • Jung, T.T.K.1    Juhn, S.K.2    Hwang, D.3
  • 21
    • 0030730123 scopus 로고    scopus 로고
    • Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps
    • Pinto S, Gallo O, Polli G, et al. Cyclooxygenase and lipoxygenase metabolite generation in nasal polyps. Prostaglandins Leukot Essent Fatty Acids 1997; (6): 533-7
    • (1997) Prostaglandins Leukot Essent Fatty Acids , Issue.6 , pp. 533-537
    • Pinto, S.1    Gallo, O.2    Polli, G.3
  • 22
    • 0028884734 scopus 로고
    • Arachidonic acid metabolites and sinonasal polyposis: I. Possible prognostic value
    • Klapan I, Culo F, Culig J, et al. Arachidonic acid metabolites and sinonasal polyposis: I. Possible prognostic value. Am J Otolaryngol 1995; 16 (6): 396-402
    • (1995) Am. J. Otolaryngol. , vol.16 , Issue.6 , pp. 396-402
    • Klapan, I.1    Culo, F.2    Culig, J.3
  • 23
    • 0029901768 scopus 로고    scopus 로고
    • Eicosanoids from biopsy of normal and polypous nasal mucosa
    • Baenkler HW, Schafer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology 1996; 34 (3): 166-70
    • (1996) Rhinology , vol.34 , Issue.3 , pp. 166-170
    • Baenkler, H.W.1    Schafer, D.2    Hosemann, W.3
  • 24
    • 0032772316 scopus 로고    scopus 로고
    • Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics
    • Picado C, Fernandez-Morata JC, Juan M, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Care Med 1999; 160: 291-6
    • (1999) Am. J. Respir. Care Med. , vol.160 , pp. 291-296
    • Picado, C.1    Fernandez-Morata, J.C.2    Juan, M.3
  • 25
    • 0032782372 scopus 로고    scopus 로고
    • Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease
    • American Rhinologic Society Spring Meeting; Palm Beach (FL) 1998
    • Ulualp SO, Sterman BM, Toohill RJ. Antileukotriene therapy for the relief of sinus symptoms in aspirin triad disease. American Rhinologic Society Spring Meeting; Palm Beach (FL) 1998. Ear Nose Throat J 1999; 72: 604-16
    • (1999) Ear Nose Throat J. , vol.72 , pp. 604-616
    • Ulualp, S.O.1    Sterman, B.M.2    Toohill, R.J.3
  • 26
    • 0033968891 scopus 로고    scopus 로고
    • Acute effects of antileukotrienes on sinusitis and sinonasal polyposis 1999
    • Parnes SM, Chuma AV. Acute effects of antileukotrienes on sinusitis and sinonasal polyposis 1999. Ear Nose Throat J 1999; 79: 18-25
    • (1999) Ear Nose Throat J. , vol.79 , pp. 18-25
    • Parnes, S.M.1    Chuma, A.V.2
  • 27
    • 0034846823 scopus 로고    scopus 로고
    • An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma
    • Ragab S, Parikh A, Darby YC, et al. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma. Clin Exp Allergy 2001; 31 (9): 1385-91
    • (2001) Clin. Exp. Allergy , vol.31 , Issue.9 , pp. 1385-1391
    • Ragab, S.1    Parikh, A.2    Darby, Y.C.3
  • 28
    • 0034764333 scopus 로고    scopus 로고
    • Treatment of ASS-associated polyposis (ASSAP) with a Cysteinyl leukotriene receptor antagonist: A prospective drug study on its antiinflammatory effects [in German]
    • Grundmann T, Topfner M. Treatment of ASS-associated polyposis (ASSAP) with a Cysteinyl leukotriene receptor antagonist: a prospective drug study on its antiinflammatory effects [in German]. Laryngorhinootologie 2001; 80 (10): 576-82
    • (2001) Laryngorhinootologie , vol.80 , Issue.10 , pp. 576-582
    • Grundmann, T.1    Topfner, M.2
  • 29
    • 0034305846 scopus 로고    scopus 로고
    • Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome
    • Di Rienzo L, Artuso A, Cerqua N. Antileukotrienes in the prevention of postoperative recurrence of nasal polyposis in ASA syndrome. Acta Otorhinolaryngol Ital 2000; 20 (5): 336-42
    • (2000) Acta Otorhinolaryngol. Ital. , vol.20 , Issue.5 , pp. 336-342
    • Di Rienzo, L.1    Artuso, A.2    Cerqua, N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.